National Institute of General Medical Sciences; Notice of Closed Meeting, 27154 [E9-13199]
Download as PDF
27154
Federal Register / Vol. 74, No. 108 / Monday, June 8, 2009 / Notices
2002–2004 of 5.93% increase to 12.54%
for 2005–2007.
The reduction in the earlier years IMR
(2002–2004) for Central Harlem made
them ineligible for the FY 2009 Healthy
Start Eliminating Disparities Open
competition. To be eligible, the IMR for
the service area had to be 1.5 times the
national average for the period of 2002–
2004 or 10.35. In FY 2010 there will be
another Healthy Start Eliminating
Disparities Open competition and
grantees will be required to the use the
most recently available IMR data (2004–
2006 or 2005–2007) to compete. To be
eligible for the competition, grantees
will have to have an IMR that is 1.5
times the national average for the
project area for either 2004–2006 or
2005–2007. Data supplied the New York
City Bureau Statistics indicates that
Central Harlem would be eligible for
this competition because they have
12.54% IMR for teen births for 2005–
2007.
The award of non-competitive
supplemental funding will enable
NMPP to provide much need services in
Central Harlem. Given the current
economic situation and the rising IMR
rate in the project area, the loss of this
experienced provider of health services
would be devastating and would
contribute to the rise in infant deaths in
Central Harlem, NMPP is the primary
provider of comprehensive communitybased perinatal services and the only
Healthy Start site serving the project
area. The project’s dedication and
commitment to the residents of Harlem
since 1999 could not be replaced
another community based provider.
FOR FURTHER INFORMATION CONTACT: John
McGovern, Public Health Analyst,
Division of Healthy Start and Perinatal
Services, Maternal and Child Health
Bureau, HRSA, Room 18–12, Parklawn
Building, 5600 Fishers Lane, Rockville,
MD 20857; phone 301–443–5805; E-mail
jmcgovern@hrsa.gov.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
General Medical Sciences Special Emphasis
Panel Competitive Revision—ARRA Funds.
Date: June 11, 2009.
Time: 1:45 p.m. to 3:45 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, Room 3AN18, 45 Center
Drive, Bethesda, MD 20892. (Telephone
Conference Call).
Contact Person: Rebecca H Johnson, PhD,
Scientific Review Administrator, Office of
Scientific Review, National Institute of
General Medical Sciences, National Institutes
of Health, Natcher Building, Room 3AN18C,
Bethesda, MD 20892. 301–594–2771.
johnsonrh@nigms.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.375, Minority Biomedical
Research Support; 93.821, Cell Biology and
Biophysics Research; 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.862, Genetics and
Developmental Biology Research; 93.88,
Minority Access to Research Careers; 93.96,
Special Minority Initiatives; 93.701, ARRA
Related Biomedical Research and Research
Support Awards, National Institutes of
Health, HHS)
Dated: June 1, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–13199 Filed 6–5–09; 8:45 am]
BILLING CODE 4140–01–M
Dated: May 29, 2009.
Mary K. Wakefield,
Administrator.
[FR Doc. E9–13279 Filed 6–5–09; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
BILLING CODE 4165–15–P
National Institutes of Health
National Institutes of Health
cprice-sewell on PRODPC61 with NOTICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institute of Biomedical
Imaging and Bioengineering; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
National Institute of General Medical
Sciences; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
VerDate Nov<24>2008
15:15 Jun 05, 2009
Jkt 217001
PO 00000
Frm 00067
Fmt 4703
Sfmt 4703
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Biomedical Imaging and Bioengineering
Special Emphasis Panel—Program Project.
Date: July 10, 2009.
Time: 1 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: NIH, Democracy II, 6701 Democracy
Plaza II, 200, Bethesda, MD 20892, (Virtual
Meeting).
Contact Person: John K. Hayes, PhD,
Scientific Review Officer, 6707 Democracy
Boulevard, Suite 959, Bethesda, MD 20892,
301–451–3398, hayesj@mail.nih.gov.
Dated: June 1, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–13282 Filed 6–5–09; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel. Animal Models of Infectious
Diseases 1.
Date: June 29–July 1, 2009.
Time: 8 a.m. to 7 p.m.
Agenda: To review and evaluate contract
proposals.
Place: Crowne Plaza—Silver Spring, 8777
Georgia Avenue, Silver Spring, MD 20910.
Contact Person: Tracy A. Shahan, PhD,
MBA, Scientific Review Officer, Scientific
Review Program, NIH/NIAID/DHHS, Room
3121, 6700B Rockledge Drive, MSC 7616,
E:\FR\FM\08JNN1.SGM
08JNN1
Agencies
[Federal Register Volume 74, Number 108 (Monday, June 8, 2009)]
[Notices]
[Page 27154]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-13199]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of General Medical Sciences; Notice of Closed
Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of General Medical
Sciences Special Emphasis Panel Competitive Revision--ARRA Funds.
Date: June 11, 2009.
Time: 1:45 p.m. to 3:45 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Natcher Building, Room
3AN18, 45 Center Drive, Bethesda, MD 20892. (Telephone Conference
Call).
Contact Person: Rebecca H Johnson, PhD, Scientific Review
Administrator, Office of Scientific Review, National Institute of
General Medical Sciences, National Institutes of Health, Natcher
Building, Room 3AN18C, Bethesda, MD 20892. 301-594-2771.
johnsonrh@nigms.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance Program Nos. 93.375,
Minority Biomedical Research Support; 93.821, Cell Biology and
Biophysics Research; 93.859, Pharmacology, Physiology, and
Biological Chemistry Research; 93.862, Genetics and Developmental
Biology Research; 93.88, Minority Access to Research Careers; 93.96,
Special Minority Initiatives; 93.701, ARRA Related Biomedical
Research and Research Support Awards, National Institutes of Health,
HHS)
Dated: June 1, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E9-13199 Filed 6-5-09; 8:45 am]
BILLING CODE 4140-01-M